Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
USA v. Babich et al
Case Number:
1:16-cr-10343
Court:
Nature of Suit:
Judge:
Firms
- Brown Rudnick
- Clark Hill
- Donnelly Conroy
- Fick & Marx
- Fitch Law Partners
- Hogan Lovells
- King & Spalding
- Kobre & Kim
- Miner Siddall
- Mitchell Stein Carey
- Morgan Lewis
- Nixon Peabody
- Ropes & Gray
- Weil Gotshal
- White & Case
- Wilkinson Stekloff
Companies
Sectors & Industries:
-
September 10, 2019
Weil Downplayed Atty Conflict, Convicted Insys Exec Says
Weil Gotshal & Manges LLP misled a convicted Insys executive about the firm's conflicts, telling him the fact that the firm also represented Insys while the company cooperated with the government meant "nothing" to him, his new legal team told a Massachusetts federal court Tuesday.
-
August 16, 2019
Weil's Bid To Intervene In Insys Conflict Faces Opposition
The new firm representing a convicted Insys Therapeutics sales director told a Boston federal judge Friday that Weil Gotshal & Manges LLP should not be allowed to intervene in his case after the executive accused Weil of improperly representing him and the company at the same time.
-
August 08, 2019
Gov't Fights Insys Founder's Bid To Delay Sentencing
Federal prosecutors in Boston pushed back Thursday against an attempt by Insys Therapeutics Inc. founder John Kapoor to delay his sentencing over a counsel conflict, saying he has enough lawyers to handle the hearing and should be sentenced around the same time as other former Insys executives.
-
July 29, 2019
'No Miscarriage Of Justice' In Insys Execs' Trial, Feds Say
Federal prosecutors defended the jury verdict that found five former Insys Therapeutics Inc. executives guilty of bribing doctors to prescribe opioids to patients who didn't need them, arguing in a voluminous filing late Friday that the panel got it right and there was "no miscarriage of justice."
-
July 19, 2019
Massachusetts Cases To Watch: Midyear Report
Boston courthouses have been hopping as spring has turned to summer and high-profile white collar cases, the anticipated verdict in a landmark education and employment case, and a pair of cases dealing with courthouse immigration arrests have been filling up the Bay State's dockets. Here, Law360 highlights some of the most important cases to watch in the second half of 2019.
-
July 16, 2019
Former Insys Execs Want Sentencing Delayed Until 2020
A group of former Insys Therapeutics Inc. executives convicted of bribing doctors to prescribe a powerful opioid have asked a federal judge to delay sentencing them until January, since she delayed sentencing two others who pled guilty and are still cooperating with the government.
-
July 08, 2019
Ex-Insys Bosses Still Aiding 8 Kickback Probes, Feds Say
Prosecutors told a Boston federal judge on Monday that a pair of former Insys Therapeutics Inc. executives who pled guilty to a scheme to bribe doctors to prescribe opioids are still cooperating in at least eight related investigations, asking that their sentencing hearings be delayed by four months.
-
May 13, 2019
Insys Faces $18M Bill For Final Stretch Of Founder's Trial
Insys Therapeutics may have to shell out over $18 million in legal costs for founder John Kapoor for the first quarter of 2019, the final stretch of a lengthy racketeering trial that ended in his conviction earlier this month, the opioid manufacturer said Monday.
-
May 07, 2019
Insys Jurors Say They Thought Execs Were Guilty Early On
The Boston federal jury that deliberated for 15 days before convicting five former Insys Therapeutics executives of racketeering conspiracy last week believed early on in their discussions that all of the defendants were likely guilty, then dug through troves of evidence to find the documents that proved it, two of the jurors told Law360.
-
May 03, 2019
Conviction Of Insys Execs Will Embolden Gov't In Opioid Fight
A Boston jury sent a message that will both resonate in the pharmaceutical industry and embolden already aggressive opioid prosecutions when it convicted five former Insys Therapeutics Inc. executives of bribing doctors to prescribe opioids, experts said after Thursday's landmark verdict.